A Progressive Practice in Psychiatry
Our Focus
Alleviate the symptoms of Treatment Resistant Despression within 5 days or less with Accelerated TMS.
Effective deep TMS treatments are administered using the Brainsway® system, thereby mitigating the need for neuronavigation
We specialize in accelerated TMS treatments that can provide relief for the most treatment resistant patients in 5 days or less
We also provide conventional TMS treatments that are covered by select insurance plans.
Alleviate the symptoms of Major Depressive Disorder and acute suicidal ideation and/or behaviors within 24 hours or less with Spravato®.
Esketamine, also known by the brand name Spravato®, is a promising new antidepressant that has the potential to work very quickly
Esketamine is chemically related to ketamine and is self-administered as a nasal spray
Unlike previous antidepressants, many patients feel better after the first or second treatment
Esketamine works in 50–70% of patients with treatment-resistant depression.
Our Approach
We are committed to providing forward-thinking, personalized treatment experiences for individuals struggling with depression, anxiety, OCD and more.
We are patient-centered, thoughtful, and intentional. We provide a boutique patient experience coupled with our personalized treatment solutions backed by science.
Additionally, we are trained by MAPS to offer MDMA assisted therapy for treatment-resistant PSTD pending FDA-approval, and are committed to staying at the forefront of psychedelic medicine.
Our Thinking
Patient Referral
Are you a healthcare provider who would like to refer a patient? Please complete a short referral form using the link below.
Refer a Patient
A Progress Practice in Psychiatry
©2024 Clear Path Psychiatry, Inc.
